SEC Filings for Ayala Pharmaceuticals, Inc.
NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Form Type: NT 10-K
Filing Date: 2023-01-30
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2023-01-30
View Filing
SC 13G - Statement of Beneficial Ownership by Certain Investors
Form Type: SC 13G
Filing Date: 2023-01-30
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2023-01-25
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2023-01-13
View Filing
425 - Prospectuses and communications, business combinations
Form Type: 425
Filing Date: 2023-01-12
View Filing
8-K - Current report
Form Type: 8-K
Filing Date: 2023-01-12
View Filing
424B3 - Prospectus [Rule 424(b)(3)]
Form Type: 424B3
Filing Date: 2023-01-05
View Filing
DEF 14A - Other definitive proxy statements
Form Type: DEF 14A
Filing Date: 2022-12-13
View Filing
EFFECT - Notice of Effectiveness
Form Type: EFFECT
Filing Date: 2022-12-12
View Filing
